Publications by authors named "Catherine Rugg"

Claim this Profile
H
High-content phenotypic screening and triaging strategy to identify small molecules driving oligodendrocyte progenitor cell differentiation.
Jane V Peppard, Catherine A Rugg, Matthew A Smicker, Elaine Powers, Erica Harnish

J Biomol Screen· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allergen-induced production of IL-31 by canine Th2 cells and identification of immune, skin, and neuronal target cells.
Erin E McCandless, Catherine A Rugg, Gregory J Fici, James E Messamore, Michelle M Aleo

Vet Immunol Immunopathol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
7
7-[1H-Indol-2-yl]-2,3-dihydro-isoindol-1-ones as dual Aurora-A/VEGF-R2 kinase inhibitors: design, synthesis, and biological activity.
Terry V Hughes, Stuart L Emanuel, Harold R O'Grady, Peter J Connolly, Catherine Rugg

Bioorg Med Chem Lett· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cellular and in vivo activity of JNJ-28871063, a nonquinazoline pan-ErbB kinase inhibitor that crosses the blood-brain barrier and displays efficacy against intracranial tumors.
Stuart L Emanuel, Terry V Hughes, Mary Adams, Catherine A Rugg, Angel Fuentes-Pesquera

Mol Pharmacol· February 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of the ABCG2 drug transporter in the resistance and oral bioavailability of a potent cyclin-dependent kinase/Aurora kinase inhibitor.
Jennifer A Seamon, Catherine A Rugg, Stuart Emanuel, Anna Maria Calcagno, Suresh V Ambudkar

Mol Cancer Ther· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The in vitro and in vivo effects of JNJ-7706621: a dual inhibitor of cyclin-dependent kinases and aurora kinases.
Stuart Emanuel, Catherine A Rugg, Robert H Gruninger, Ronghui Lin, Angel Fuentes-Pesquera

Cancer Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and identification of [1,3,5]triazine-pyridine biheteroaryl as a novel series of potent cyclin-dependent kinase inhibitors.
Gee-Hong Kuo, Alan Deangelis, Stuart Emanuel, Aihua Wang, Yan Zhang, Catherine Rugg

J Med Chem· July 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
1-Acyl-1H-[1,2,4]triazole-3,5-diamine analogues as novel and potent anticancer cyclin-dependent kinase inhibitors: synthesis and evaluation of biological activities.
Ronghui Lin, Peter J Connolly, Shenlin Huang, Steven K Wetter, Yanhua Lu, Catherine A Rugg

J Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis